Kline Kyle's Form 4 filing
Globus Medical Inc (GMED) · filed Dec 3, 2025
- Accession no.
- 0001193125-25-307215
- Filed
- Dec 3, 2025
- Trade date
- Dec 1, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $1.67M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001193125-26-011926 (Jan 13, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kline KyleCIK 0002080625 | Officer (Senior Vice President, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Class A Common Stock | MOption exerciseAcquired | +3,646 | $53.14 | +$193,748.44 | 3,646 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseAcquired | +5,000 | $56.43 | +$282,150 | 8,646 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseAcquired | +5,000 | $64.44 | +$322,200 | 13,646 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseAcquired | +4,896 | $63.68 | +$311,777.28 | 18,542 | Direct | |
| Dec 1, 2025 | Class A Common Stock | SSaleDisposed | −18,542 | $90.00 | −$1,668,780 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | Class A Common Stock | MOption exerciseDisposed | −3,646 | $0.00 | $0 | 1,354 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 10,000 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct | |
| Dec 1, 2025 | Class A Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.